Suitability of Xpert MTB/RIF and Genotype MTBDRplus for Patient Selection for a Tuberculosis Clinical Trial

Evaluation of the Analytical Performance of the Xpert MTB/RIF Assay

(2010) R. Blakemore et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Containment of Bioaerosol Infection Risk by the Xpert MTB/RIF Assay and Its Applicability to Point-of-Care Settings

(2010) P. P. Banada et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis

(2010) Neel R Gandhi et al.   LANCET

Rapid Molecular Detection of Tuberculosis and Rifampin Resistance

(2010) Catharina C. Boehme et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rapid Detection ofMycobacterium tuberculosisand Rifampin Resistance by Use of On-Demand, Near-Patient Technology

(2009) Danica Helb et al.   JOURNAL OF CLINICAL MICROBIOLOGY

South Africa tries new approach to resistant tuberculosis

(2009) Clare Kapp   LANCET

Rapid Molecular Screening for Multidrug-Resistant Tuberculosis in a High-Volume Public Health Laboratory in South Africa

(2008) Marinus Barnard et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The early bactericidal activity of anti-tuberculosis drugs: a literature review

(2008) P.R. Donald et al.   TUBERCULOSIS